[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337045-105":59,"doc-detail-337045-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-the-mevalonate-pathway-enhances-the-efficacy-of-5-fluorouracil-by-regulating-pyroptosis","Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosis","","5-fluorouracil (5-FU)-based chemotherapy is a key option for pancreatic cancer, but 5-FU resistance limits long-term benefit. Clinical sample analyses identified HMGCR, a rate-limiting mevalonate pathway enzyme, as negatively associated with 5-FU efficacy. HMGCR correlated with the pyroptosis marker GSDMD, and inhibition by simvastatin suppressed pyroptosis signaling. Added GGPP reduced 5-FU sensitivity, while simvastatin plus 5-FU showed synergy and inhibited tumor growth in organoids and genetically engineered mice.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-the-mevalonate-pathway-enhances-the-efficacy-of-5-fluorouracil-by-regulating-pyroptosis/337045/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-the-mevalonate-pathway-enhances-the-efficacy-of-5-fluorouracil-by-regulating-pyroptosis/337045.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the relationship between HMGCR and 5-FU efficacy in pancreatic cancer?","Question",{"text":112,"@type":113},"HMGCR expression is negatively correlated with the efficacy of 5-FU treatment in pancreatic cancer clinical samples.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the mevalonate pathway influence pyroptosis and 5-FU resistance?",{"text":117,"@type":113},"HMGCR correlates with the pyroptosis marker GSDMD, and simvastatin can inhibit activation of pyroptosis signaling. GGPP addition reduces 5-FU sensitivity.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is simvastatin combined with 5-FU considered a promising strategy?",{"text":121,"@type":113},"Simvastatin plus 5-FU shows a strong synergistic effect, significantly suppressing tumor growth in organoid models and genetically engineered mice with spontaneous pancreatic cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337045,1790860176,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Medical Oncology (2025) 42:9  \n[https://doi.org/10.1007/s12032-024-02557-5](https://doi.org/10.1007/s12032-024-02557-5)  \nTargeting the mevalonate pathway enhances the efficacy of 5‑fluorouracil by regulating pyroptosis  \nZongrui Xing1,2 · Yong Ma1,2 · Xiangyan Jiang1,2 · Huiguo Qing1,2 · Yuxia Wu1,2 · Shengfu Che1,2 · Zhongti Gao1,2 · Keshen Wang1,2 · Tao Wang1,2 · Qichen He1,2 · Zhigang Li1,2 · Bin Zhao1,2 · Wenbo Liu1,2 · Haonan Sun1,2 · Zeyuan Yu1,3  \nReceived: 3 September 2024 / Accepted: 6 November 2024 / Published online: 20 November 2024 © The Author(s) 2024  \nAbstract  \nThe 5-fluorouracil (5-FU)-based chemotherapy regimen is a primary strategy for treating pancreatic cancer (PC) . However, challenges related to 5-FU resistance persist. Investigating the mechanisms of 5-FU resistance and identifying a clinically viable therapeutic strategy are crucial for improving the prognosis of PC. Here, through clinical samples analysis, we found that the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), the rate-limiting enzyme in mevalonate metabolism, is negatively correlated with the efficacy of 5-FU treatment. There is a significant correlation between HMGCR and the pyroptosis marker gasdermin D (GSDMD), and the HMGCR inhibitor simvastatin can significantly inhibit the activation of pyroptosis signaling. The exogenous addition of geranylgeranyl pyrophosphate (GGPP), a key metabolite of the mevalonate pathway, can significantly reduce sensitivity to 5-FU, and simvastatin combined with 5-FU demonstratesa strong synergistic effect. Furthermore, in organoid models and genetically engineered mice with spontaneous PC, the combination of simvastatin and 5-FU significantly inhibits tumor growth. In conclusion, our study reveals the critical role of the mevalonate pathway in 5-FU resistance and proposes a clinically feasible combination therapy strategy.  \nKeywords 5-Fluorouracil · Mevalonate pathway · Pyroptosis · Pancreatic cancer · Chemoresistance  \nIntroduction  \nDespite recent advances in pancreatic cancer (PC) treatment, it remains a significant challenge, with a 5-year survival rate of less than 10%[1, 2] . The National Comprehensive Cancer Network Pancreatic Cancer guidelines recommend that the modified FOLFIRINOX regimen will bring longer median survival. Among them, 5-fluorouracil (5-FU) is the cornerstone of the therapeutic protocol, and 5-FU-based  \nZongrui Xing, Yong Ma, Xiangyan Jiang, and Huiguo Qing have equally contributed to this work.  \n* Zeyuan Yu[yuzy17@lzu.edu.cn](yuzy17@lzu.edu.cn)  \n1 Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu, China  \n2 The Second School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China  \n3 Gansu Province High-Altitude High-Incidence Cancer Biobank, Lanzhou University Second Hospital, Lanzhou 730030, China  \nFOLFIRINOX is recommended for patients with PC after surgery [3] 0.5-FU, a cell cycle-specific uracil analog, interacts with DNA,RNA, or both, leading to its accumulation in cells, and causing tumor cell damage and death [4] . Therefore, 5-FU plays an indispensable role in the treatment process of PC [5, 6] . However, due to the low stability of 5-FU in cells and the susceptibility to drug resistance, only a minority of patients benefit from FOLFIRINOX [7–9] . Tumor metabolic reprogramming enhances tumor progression by disrupting the anti-tumor metabolic activity of 5-FU. Elevated glucose metabolism and increased enzyme expression diminish the drug's effectiveness [10, 11]. Additionally, the accumulation of lipid droplets and the overexpression of the nuclear protein sterol-regulatory element-binding protein-1 impede the anticancer effect of 5-FU [12, 13] . Consequently, further investigation into how tumor metabolic reprogramming regulates 5-FU chemotherapy resistance is crucial for enhancing the effectiveness of the FOLFIRINOX regimen.  \nThe mevalonate pathway, a critical pathway for cholesterol synthesis, plays a ","cbCaifAx4QR7cuNM","https://ap.wps.com/l/cbCaifAx4QR7cuNM","pdf",2443981,11,"English","# Abstract\n# Introduction\n# Materials and methods\n## Human PC clinical specimens","[{\"question\":\"What is the relationship between HMGCR and 5-FU efficacy in pancreatic cancer?\",\"answer\":\"HMGCR expression is negatively correlated with the efficacy of 5-FU treatment in pancreatic cancer clinical samples.\"},{\"question\":\"How does the mevalonate pathway influence pyroptosis and 5-FU resistance?\",\"answer\":\"HMGCR correlates with the pyroptosis marker GSDMD, and simvastatin can inhibit activation of pyroptosis signaling. GGPP addition reduces 5-FU sensitivity.\"},{\"question\":\"Why is simvastatin combined with 5-FU considered a promising strategy?\",\"answer\":\"Simvastatin plus 5-FU shows a strong synergistic effect, significantly suppressing tumor growth in organoid models and genetically engineered mice with spontaneous pancreatic cancer.\"}]","Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosis | PDF",1790017517,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ab859464571fcb0099db2ff3f24d38a.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a21b2b48c070fb83e1f20c2d0d4f3be2.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63f1ada7d47507d1e0db66f0ae89bd68.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60bf416fe2a4033551469abf87666c69.webp",980,1301]